Advertise on podcast: Theragnostic Talks

Rating

from

2 reviews

Description

Very welcome to Theragnostic Talks by SAM Nordic, the one and only podcast about theragnostic. What is even theragnostic? And what does the future for it look like? In this podcast we will find out interesting science and get answers to curious questions by talking with true experts - clinicians, scientists and people from the industry. And to guide you through these episodes – Annette Andrén and Gustav Widar. Annette is driven by the transformation of science into value for patients. Her background as a chemical engineer - with focus on biochemistry - has led her to different positions such as country manager and market access director in the Nordics. She has been working both within a large variety of different therapy areas and with breakthrough treatments for inflammation and autoimmune diseases. What she likes the most is when she is able to help out in the identification of scientific opportunities for collaborations between Health care, Research and the Industry. She is currently senior medical science liaison at SAM Nordic. Gustav has a background as a licensed medical physicist and has worked many years in the field of nuclear medicine – covering imaging, therapy and the production of radiopharmaceuticals. He is driven by making medical innovations a clinical reality – where it really benefits the patient care. A couple of years ago he changed from healthcare to industry, now medical science liaison at SAM Nordic.

Podcast episodes

Check latest episodes from Theragnostic Talks podcast

Unlocking the potential of biomarkers in cancer treatment

2022/01/18

Using biomarkers from a blood test: can that optimize the treatment for prostate cancer? Listen to Professor Henrik Grönberg, who recently received the award “Cancer Researcher of the Year in 2022” by the Swedish Cancer Society. He tells us about the ProBio study which has the potential to revolutionize the treatment of prostate cancer. Guest: Professor Henrik Grönberg By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

A passionate journey with theragnostics

2021/11/03

– I tell my kids that I am probably not going to see them a lot but I am going to do stuff for a lot of patients out there who are living miserable lives. That is my motivation, to make somebody feel better. In this episode of Theragnostic Talks we get to meet Dr Laura Ravasi. She is Head of Global Medical Affairs at Telix Pharmaceuticals and travels all over Europe to find out more about the challenges and possibilities of tomorrow. Join us on the journey, from proof of concept to theragnostics of today. Guest: Dr Laura Ravasi By: Annette Andren and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

The father of theragnostics

2021/10/20

When she found boxes of her father´s original work, Barbara Hertz decided to put all the puzzle pieces together. This episode of Theragnostic Talks is about Saul Hertz, the father of theragnostics. Saul Hertz was the first medical doctor to use radioactive iodine to treat hyperthyroidism, he pioneered the first targeted cancer therapies. Listen to his daughter Barbara telling us about his discoveries and insights, his eureka moment and about the fact that other people took credit for his work. Guest: Barbara Hertz By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

Astatine-211 – Swedish start-up pushing cancer therapy to the next level with Emma Aneheim

2021/09/29

How can the most rare radioactive chemical element on earth be used in treatment for ovarian cancer? Listen to Postdoctoral Researcher Emma Aneheim talk about how their start-up company Alpha Therapy Solutions use Astatine-211 in combination with antibodies. What are the main benefits? And when will using Astatine-211 in cancer treatment be reality? Please join us in this week’s exciting episode of Theragnostic Talks. Guest: Postdoctoral Researcher Emma Aneheim By: Anette Andren and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

Lack of evidence? Is consensus an option? – with Silke Gillessen

2021/09/15

If you don´t have good evidence, the second best you can have is consensus from experts in the field. Meet Professor Silke Gillessen, one of the world´s leading experts in GU oncology and the lead organizer of APCCC, a conference where the world´s top prostate cancer experts get together. What are the main hot topics at the moment? And what difference does it really make for prostate cancer care, gathering this expertise? Please join us in this episode of Theragnostic Talks Guest: Prof. Silke Gillessen By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

From academia to start-up

2021/09/01

It takes persistence to turn preclinical research into business. And it takes great teamwork to make it successful. In this episode of Theragnostic Talks we get to meet Dr Frances Johnson and Dr Michael Schultz. They founded Viewpoint Molecular Targeting, a radiopharmaceutical company with a theragnostic portfolio. Hear them talk about challenges along the way and why they believe in Alpha emitting isotopes. Enjoy! Guests: Dr Frances Johnson, Dr Michael Schultz By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

ProPSMA and TheraP – changing patient care - with Michael Hofman

2021/08/18

Professor Michael Hofman has contributed to some of the most important progress for imaging and treatment of prostate cancer. And his collaborative approach has brought together multi-disciplinary expertise from more than 10 centers around Australia. – If you have the energy to put together a clinical trial protocol I bet colleagues around your country will be happy to adopt it. It is a win-win for everyone. Please join us in this episode of Theragnostic Talks. Guest: Prof. Michael Hofman By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

The lucky, PET-addicted guy – with Stefano Fanti

2021/08/05

By collaboration we can improve the scientific results and really make a difference. Don't miss this episode with the committed professor Stefano Fanti, devoted to his mission and always eager to spread the word about PET and prostate imaging. Ending up with breaking news about the EANM congress… Enjoy! Guest: Prof. Stefano Fanti By: Annette Andrén and Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

Turned family loss to stronger patient voice – with Simone Leyden

2021/07/07

When Simone Leyden lost her 34 year old sister in a rare GI cancer she and her brother John decided to start a foundation. What struck them, when their sister was struggling, was that there was a huge difference in treatment and support for less common cancers, compared to more common ones. Please join us and listen to this episode of Theragnostic Talks Simone, founder and CEO of NeuroEndocrine Cancer. Guest: Simone Leyden, co-founder and CEO NeuroEndocrine Cancer By: Gustav Widar & Annette Andrén Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

”This is the theragnostic breakthrough” – with Oliver Sartor, Bernd Krause and Ken Hermann

2021/06/23

We gathered up with Oliver Sartor, Bernd Krause and Ken Hermann, co-authors of the VISION study, to talk about how it will impact the treatment of prostate cancer. The VISION study is the first international randomized open label phase III study that shows convincing results for a novel treatment of late-stage advanced prostate cancer. A targeted treatment for prostate cancer using radioactive 177Lu-PSMA-617. Successful? Without a doubt if you ask Oliver Sartor. – This is the theragnostic breakthrough we all have been waiting for. It's going to change the way we treat cancer. Join us on Theragnostic Talks! Guest: Oliver Sartor, Bernd Krause, Ken Hermann By: Gustav Widar Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

ImmunoPET, predicting response to therapy - with Anna Wu

2021/06/09

What is immunoPET and radio immunotherapy? Meet Anna Wu, professor at City of Hope and research professor at UCLA, California. She explains why antibodies can be used instead of small molecules or peptides, how to use immunoPET for patient selection in immunotherapy and why a revolution of precision health is on its way. Guest: Anna Wu By: Gustav Widar and Annette Andrén Contact us: podcast@samnordic.se For more info, visit www.samnordic.se

Renaissance for radioligand therapy - with Germo Gericke

2021/05/26

In 5 to 10 years we are going to use theragnostics predominantly in combination with other therapies. Why? Because it gives us the opportunity to treat cancer in a totally different way. It's also a step forward to more personalized treatment. In this episode of Theragnostic Talks you get to meet Germo Gericke, Medical Officer at AAA. Enjoy! We apologize for bad sound quality in the beginning of this episode, but hold on – it gets better after 10 minutes. Guest: Germo Gericke By: Gustav Widar and Annette Andrén Contact us: podcast@samnordic.se For more info, visit www.samnordic.se